Brief: Yichang Hec Changjiang Pharmaceutical Updates On Approval Of Olanzapine Orally-Disintegrating Tablets (5 Mg)
June 1 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* OLANZAPINE ORALLY-DISINTEGRATING TABLETS (5 MG) OBTAINED
APPROVAL FOR LAUNCH FROM CNMPA
Source text for Eikon: ID:nHKS7qGvy7
Further company coverage: 1558.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million